Business Context and Reporting Period
This Form 8-K Current Report was filed by BXP, Inc. and Boston Properties Limited Partnership on March 6, 2026. The filing primarily addresses the establishment of a new capital raising mechanism and the replacement of expiring shelf registration statements.
Key Financial Metrics and Capital Structure
The filing does not report operational financial metrics such as revenue, profit, cash flow, or margins. The primary financial data relates to capital market activities:
- Equity Offering Capacity: Establishment of a new $1.0 billion "at the market" equity offering program.
- Program Duration: The offering program has a term of up to three years.
- Transaction Costs: Sales agents are entitled to compensation not exceeding 2.0% of the gross sales price. Forward sellers receive a commission in the form of a reduced initial forward sale price, not exceeding 2.0% of the volume-weighted average sales price.
- Other Securities: The filing covers the issuance of up to 152,905 shares for unit redemptions and the resale of up to 13,252,000 shares related to 2.00% Exchangeable Senior Notes due 2030.
Material Changes Versus Prior Period
The filing details the following material changes to the Company's capital raising capabilities:
- Program Expansion: The new $1.0 billion "at the market" program replaces the prior $600 million program, which was scheduled to expire on May 17, 2026.
- Registration Replacement: A new automatic shelf registration statement (File No. 333-294080) was filed to replace an existing statement expiring on May 17, 2026. A separate shelf registration (File No. 333-294079) was filed for the Dividend Reinvestment and Stock Purchase Plan.
- Forward Sale Mechanism: The new Sales Agreement introduces the option to engage in forward sale transactions with specific Forward Purchasers and Sellers, allowing for the borrowing and selling of shares to establish an initial forward sale price.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The Company has no obligation to sell any shares under the new program. Actual sales will depend on market conditions, the trading price of common stock, capital needs, and management's determination of appropriate funding sources. The Company or its agents may suspend or terminate the Sales Agreement at any time.
Risks and Contingencies: The filing notes that the forward sale price is subject to daily adjustments based on a floating interest rate factor (overnight bank funding rate less a spread) and may be decreased by the amount of quarterly dividends expected during the term of the agreement. The report explicitly states it does not constitute an offer to sell securities in any state where such an offer would be unlawful.
Important Facts for Investor Verification
- Verify the current trading price of BXP common stock to assess the potential dilution impact of a $1.0 billion offering.
- Review the specific terms of the "Master Forward Confirmations" (Exhibit 1.2) to understand the mechanics and risks of the forward sale transactions.
- Monitor future filings to determine if and when the Company elects to utilize the new $1.0 billion equity program.
- Confirm the status of the 2.00% Exchangeable Senior Notes due 2030, as the filing covers the resale of shares issuable upon their exchange.